Point72 Asset Management
ORGO icon

Point72 Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Point72 Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-45,000
Closed -$143K – 2641
2023
Q3 		$143K Buy
+45,000
New +$143K ﹤0.01% 1860

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Point72 Asset Management's ORGO Position: Q1 2026 in Review

Point72 Asset Management reduced its Organogenesis Holdings (ORGO) stake by 62% in Q1 2026, selling an estimated $834K and leaving 148,358 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #3302.

Point72 Asset Management first reported a position in ORGO in Q1 2023 and has held it in 5 quarters since. The position peaked at $2.02M in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Point72 Asset Management held 148,358 shares of Organogenesis Holdings worth $352K as of Q1 2026.
  • Point72 Asset Management sold 240,888 Organogenesis Holdings shares in Q1 2026, an estimated $834K.
  • Organogenesis Holdings made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3302 holding.
  • Point72 Asset Management first reported a position in Organogenesis Holdings in Q1 2023 and has held it in 5 quarters since.
  • Point72 Asset Management's Organogenesis Holdings position peaked at $2.02M in Q4 2025.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.